BIRD vs GSK · rev $2.8M vs P/E 13, $103.31B cap
Allbirds Inc (BIRD) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Allbirds Inc (BIRD) is a apparel retail company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported BIRD revenue for 2026-06-30 was $2.8M. Net income was -$16.4M. Revenue was down 87.6% from 2026-03-31 to 2026-06-30. BIRD currently screens at market cap $85.6M.
GSK does not have a complete income-statement cache yet.
BIRD currently screens at market cap $85.6M. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the BIRD and GSK stock pages for the full models.
Not investment advice.